Global AT1 Receptor Antagonists Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin?angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
SCOPE OF THE REPORT:
The worldwide market for AT1 Receptor Antagonists is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the AT1 Receptor Antagonists in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe AT1 Receptor Antagonists Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of AT1 Receptor Antagonists, with sales, revenue, and price of AT1 Receptor Antagonists, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of AT1 Receptor Antagonists, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, AT1 Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe AT1 Receptor Antagonists sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
The worldwide market for AT1 Receptor Antagonists is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the AT1 Receptor Antagonists in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Pfizer
- Novartis
- Merck
- Astra Zeneca
- Jhonson and Johnson
- Eli Lilly and Company
- Sanofi SA
- Bristol-Myers Squibb
- Bayer
- GSK
- Teva Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Valsartan
- Telmisartan
- Losartan
- Irbesartan
- Azilsartan
- Olmesartan
- Hypertension
- Cardiovascular Diseases
- Kidney Diseases
- Other
Chapter 1, to describe AT1 Receptor Antagonists Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of AT1 Receptor Antagonists, with sales, revenue, and price of AT1 Receptor Antagonists, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of AT1 Receptor Antagonists, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, AT1 Receptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe AT1 Receptor Antagonists sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 AT1 Receptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Valsartan
1.2.2 Telmisartan
1.2.3 Losartan
1.2.4 Irbesartan
1.2.5 Azilsartan
1.2.6 Olmesartan
1.3 Market Analysis by Applications
1.3.1 Hypertension
1.3.2 Cardiovascular Diseases
1.3.3 Kidney Diseases
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.2 AT1 Receptor Antagonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 AT1 Receptor Antagonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 AT1 Receptor Antagonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astra Zeneca
2.4.1 Business Overview
2.4.2 AT1 Receptor Antagonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jhonson and Johnson
2.5.1 Business Overview
2.5.2 AT1 Receptor Antagonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 AT1 Receptor Antagonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi SA
2.7.1 Business Overview
2.7.2 AT1 Receptor Antagonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi SA AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 AT1 Receptor Antagonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer
2.9.1 Business Overview
2.9.2 AT1 Receptor Antagonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
2.10.1 Business Overview
2.10.2 AT1 Receptor Antagonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical
2.11.1 Business Overview
2.11.2 AT1 Receptor Antagonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL AT1 RECEPTOR ANTAGONISTS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global AT1 Receptor Antagonists Sales and Market Share by Manufacturer (2016-2017)
3.2 Global AT1 Receptor Antagonists Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 AT1 Receptor Antagonists Manufacturer Market Share in 2017
3.3.2 Top 6 AT1 Receptor Antagonists Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET ANALYSIS BY REGIONS
4.1 Global AT1 Receptor Antagonists Sales, Revenue and Market Share by Regions
4.1.1 Global AT1 Receptor Antagonists Sales and Market Share by Regions (2013-2018)
4.1.2 Global AT1 Receptor Antagonists Revenue and Market Share by Regions (2013-2018)
4.2 North America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.3 Europe AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.5 South America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5 NORTH AMERICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
5.1 North America AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
5.1.1 North America AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
5.1.2 North America AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
5.2 United States AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5.3 Canada AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5.4 Mexico AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6 EUROPE AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
6.1 Europe AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
6.1.1 Europe AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
6.1.2 Europe AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
6.2 Germany AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.3 UK AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.4 France AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.5 Russia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.6 Italy AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
7.1 Asia-Pacific AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
7.2 China AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.3 Japan AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.4 Korea AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.5 India AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.6 Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
8.1 South America AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
8.1.1 South America AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
8.1.2 South America AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
8.2 Brazil AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8.3 Argentina AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8.4 Colombia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
9.1 Middle East and Africa AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.3 UAE AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.4 Egypt AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.5 Nigeria AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.6 South Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
10 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET SEGMENT BY TYPE
10.1 Global AT1 Receptor Antagonists Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global AT1 Receptor Antagonists Sales and Market Share by Type (2013-2018)
10.1.2 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2013-2018)
10.2 Valsartan Sales Growth and Price
10.2.1 Global Valsartan Sales Growth (2013-2018)
10.2.2 Global Valsartan Price (2013-2018)
10.3 Telmisartan Sales Growth and Price
10.3.1 Global Telmisartan Sales Growth (2013-2018)
10.3.2 Global Telmisartan Price (2013-2018)
10.4 Losartan Sales Growth and Price
10.4.1 Global Losartan Sales Growth (2013-2018)
10.4.2 Global Losartan Price (2013-2018)
10.5 Irbesartan Sales Growth and Price
10.5.1 Global Irbesartan Sales Growth (2013-2018)
10.5.2 Global Irbesartan Price (2013-2018)
10.6 Azilsartan Sales Growth and Price
10.6.1 Global Azilsartan Sales Growth (2013-2018)
10.6.2 Global Azilsartan Price (2013-2018)
10.7 Olmesartan Sales Growth and Price
10.7.1 Global Olmesartan Sales Growth (2013-2018)
10.7.2 Global Olmesartan Price (2013-2018)
11 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET SEGMENT BY APPLICATION
11.1 Global AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
11.2 Hypertension Sales Growth (2013-2018)
11.3 Cardiovascular Diseases Sales Growth (2013-2018)
11.4 Kidney Diseases Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 AT1 RECEPTOR ANTAGONISTS MARKET FORECAST (2018-2023)
12.1 Global AT1 Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
12.2 AT1 Receptor Antagonists Market Forecast by Regions (2018-2023)
12.2.1 North America AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.2 Europe AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.3 Asia-Pacific AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.4 South America AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.5 Middle East and Africa AT1 Receptor Antagonists Market Forecast (2018-2023)
12.3 AT1 Receptor Antagonists Market Forecast by Type (2018-2023)
12.3.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2018-2023)
12.3.2 Global AT1 Receptor Antagonists Market Share Forecast by Type (2018-2023)
12.4 AT1 Receptor Antagonists Market Forecast by Application (2018-2023)
12.4.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2018-2023)
12.4.2 Global AT1 Receptor Antagonists Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 AT1 Receptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Valsartan
1.2.2 Telmisartan
1.2.3 Losartan
1.2.4 Irbesartan
1.2.5 Azilsartan
1.2.6 Olmesartan
1.3 Market Analysis by Applications
1.3.1 Hypertension
1.3.2 Cardiovascular Diseases
1.3.3 Kidney Diseases
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.2 AT1 Receptor Antagonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 AT1 Receptor Antagonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 AT1 Receptor Antagonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Astra Zeneca
2.4.1 Business Overview
2.4.2 AT1 Receptor Antagonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jhonson and Johnson
2.5.1 Business Overview
2.5.2 AT1 Receptor Antagonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 AT1 Receptor Antagonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi SA
2.7.1 Business Overview
2.7.2 AT1 Receptor Antagonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi SA AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 AT1 Receptor Antagonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bayer
2.9.1 Business Overview
2.9.2 AT1 Receptor Antagonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
2.10.1 Business Overview
2.10.2 AT1 Receptor Antagonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Teva Pharmaceutical
2.11.1 Business Overview
2.11.2 AT1 Receptor Antagonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL AT1 RECEPTOR ANTAGONISTS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)
3.1 Global AT1 Receptor Antagonists Sales and Market Share by Manufacturer (2016-2017)
3.2 Global AT1 Receptor Antagonists Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 AT1 Receptor Antagonists Manufacturer Market Share in 2017
3.3.2 Top 6 AT1 Receptor Antagonists Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET ANALYSIS BY REGIONS
4.1 Global AT1 Receptor Antagonists Sales, Revenue and Market Share by Regions
4.1.1 Global AT1 Receptor Antagonists Sales and Market Share by Regions (2013-2018)
4.1.2 Global AT1 Receptor Antagonists Revenue and Market Share by Regions (2013-2018)
4.2 North America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.3 Europe AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.5 South America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5 NORTH AMERICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
5.1 North America AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
5.1.1 North America AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
5.1.2 North America AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
5.2 United States AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5.3 Canada AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
5.4 Mexico AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6 EUROPE AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
6.1 Europe AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
6.1.1 Europe AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
6.1.2 Europe AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
6.2 Germany AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.3 UK AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.4 France AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.5 Russia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
6.6 Italy AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7 ASIA-PACIFIC AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
7.1 Asia-Pacific AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
7.2 China AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.3 Japan AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.4 Korea AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.5 India AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
7.6 Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8 SOUTH AMERICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
8.1 South America AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
8.1.1 South America AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
8.1.2 South America AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
8.2 Brazil AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8.3 Argentina AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
8.4 Colombia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA AT1 RECEPTOR ANTAGONISTS BY COUNTRIES
9.1 Middle East and Africa AT1 Receptor Antagonists Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa AT1 Receptor Antagonists Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa AT1 Receptor Antagonists Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.3 UAE AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.4 Egypt AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.5 Nigeria AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
9.6 South Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
10 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET SEGMENT BY TYPE
10.1 Global AT1 Receptor Antagonists Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global AT1 Receptor Antagonists Sales and Market Share by Type (2013-2018)
10.1.2 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2013-2018)
10.2 Valsartan Sales Growth and Price
10.2.1 Global Valsartan Sales Growth (2013-2018)
10.2.2 Global Valsartan Price (2013-2018)
10.3 Telmisartan Sales Growth and Price
10.3.1 Global Telmisartan Sales Growth (2013-2018)
10.3.2 Global Telmisartan Price (2013-2018)
10.4 Losartan Sales Growth and Price
10.4.1 Global Losartan Sales Growth (2013-2018)
10.4.2 Global Losartan Price (2013-2018)
10.5 Irbesartan Sales Growth and Price
10.5.1 Global Irbesartan Sales Growth (2013-2018)
10.5.2 Global Irbesartan Price (2013-2018)
10.6 Azilsartan Sales Growth and Price
10.6.1 Global Azilsartan Sales Growth (2013-2018)
10.6.2 Global Azilsartan Price (2013-2018)
10.7 Olmesartan Sales Growth and Price
10.7.1 Global Olmesartan Sales Growth (2013-2018)
10.7.2 Global Olmesartan Price (2013-2018)
11 GLOBAL AT1 RECEPTOR ANTAGONISTS MARKET SEGMENT BY APPLICATION
11.1 Global AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
11.2 Hypertension Sales Growth (2013-2018)
11.3 Cardiovascular Diseases Sales Growth (2013-2018)
11.4 Kidney Diseases Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 AT1 RECEPTOR ANTAGONISTS MARKET FORECAST (2018-2023)
12.1 Global AT1 Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
12.2 AT1 Receptor Antagonists Market Forecast by Regions (2018-2023)
12.2.1 North America AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.2 Europe AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.3 Asia-Pacific AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.4 South America AT1 Receptor Antagonists Market Forecast (2018-2023)
12.2.5 Middle East and Africa AT1 Receptor Antagonists Market Forecast (2018-2023)
12.3 AT1 Receptor Antagonists Market Forecast by Type (2018-2023)
12.3.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2018-2023)
12.3.2 Global AT1 Receptor Antagonists Market Share Forecast by Type (2018-2023)
12.4 AT1 Receptor Antagonists Market Forecast by Application (2018-2023)
12.4.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2018-2023)
12.4.2 Global AT1 Receptor Antagonists Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure AT1 Receptor Antagonists Picture
Table Product Specifications of AT1 Receptor Antagonists
Figure Global Sales Market Share of AT1 Receptor Antagonists by Types in 2017
Table AT1 Receptor Antagonists Types for Major Manufacturers
Figure Valsartan Picture
Figure Telmisartan Picture
Figure Losartan Picture
Figure Irbesartan Picture
Figure Azilsartan Picture
Figure Olmesartan Picture
Figure AT1 Receptor Antagonists Sales Market Share by Applications in 2017
Figure Hypertension Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Other Picture
Figure United States AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Canada AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Germany AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure France AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure UK AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Russia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Italy AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure China AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Japan AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Korea AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure India AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer AT1 Receptor Antagonists Type and Applications
Table Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis AT1 Receptor Antagonists Type and Applications
Table Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck AT1 Receptor Antagonists Type and Applications
Table Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca AT1 Receptor Antagonists Type and Applications
Table Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table Jhonson and Johnson AT1 Receptor Antagonists Type and Applications
Table Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company AT1 Receptor Antagonists Type and Applications
Table Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi SA Basic Information, Manufacturing Base and Competitors
Table Sanofi SA AT1 Receptor Antagonists Type and Applications
Table Sanofi SA AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb AT1 Receptor Antagonists Type and Applications
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer AT1 Receptor Antagonists Type and Applications
Table Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK AT1 Receptor Antagonists Type and Applications
Table GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical AT1 Receptor Antagonists Type and Applications
Table Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global AT1 Receptor Antagonists Sales by Manufacturer (2016-2017)
Figure Global AT1 Receptor Antagonists Sales Market Share by Manufacturer in 2016
Figure Global AT1 Receptor Antagonists Sales Market Share by Manufacturer in 2017
Table Global AT1 Receptor Antagonists Revenue by Manufacturer (2016-2017)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Manufacturer in 2016
Figure Global AT1 Receptor Antagonists Revenue Market Share by Manufacturer in 2017
Figure Top 3 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Top 6 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Global AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Regions (2013-2018)
Table Global AT1 Receptor Antagonists Sales Market Share by Regions (2013-2018)
Table Global AT1 Receptor Antagonists Revenue by Regions (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2013
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2017
Figure North America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure North America AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table North America AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table North America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure North America AT1 Receptor Antagonists Sales Market Share by Countries in 2013
Figure North America AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table North America AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table North America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure North America AT1 Receptor Antagonists Revenue Market Share by Countries in 2013
Figure North America AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure United States AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Canada AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Mexico AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Europe AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Europe AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Table Europe AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2016
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Germany AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UK AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure France AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Russia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Italy AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Asia-Pacific AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Countries 2017
Table Asia-Pacific AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue Market Share by Countries 2017
Figure China AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Japan AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Korea AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure India AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table South America AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table South America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure South America AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table South America AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table South America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure South America AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Brazil AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Argentina AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Colombia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table Middle East and Africa AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries in 2013
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UAE AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Egypt AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Nigeria AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Type (2013-2018)
Table Global AT1 Receptor Antagonists Sales Share by Type (2013-2018)
Table Global AT1 Receptor Antagonists Revenue by Type (2013-2018)
Table Global AT1 Receptor Antagonists Revenue Share by Type (2013-2018)
Figure Global Valsartan Sales Growth (2013-2018)
Figure Global Valsartan Price (2013-2018)
Figure Global Telmisartan Sales Growth (2013-2018)
Figure Global Telmisartan Price (2013-2018)
Figure Global Losartan Sales Growth (2013-2018)
Figure Global Losartan Price (2013-2018)
Figure Global Irbesartan Sales Growth (2013-2018)
Figure Global Irbesartan Price (2013-2018)
Figure Global Azilsartan Sales Growth (2013-2018)
Figure Global Azilsartan Price (2013-2018)
Figure Global Olmesartan Sales Growth (2013-2018)
Figure Global Olmesartan Price (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Application (2013-2018)
Table Global AT1 Receptor Antagonists Sales Share by Application (2013-2018)
Figure Global Cardiovascular Diseases Sales Growth (2013-2018)
Figure Global Kidney Diseases Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global AT1 Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Regions (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Regions (2018-2023)
Figure North America Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Europe Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Asia-Pacific Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure South America Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Middle East and Africa Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Type (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Type (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Application (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure AT1 Receptor Antagonists Picture
Table Product Specifications of AT1 Receptor Antagonists
Figure Global Sales Market Share of AT1 Receptor Antagonists by Types in 2017
Table AT1 Receptor Antagonists Types for Major Manufacturers
Figure Valsartan Picture
Figure Telmisartan Picture
Figure Losartan Picture
Figure Irbesartan Picture
Figure Azilsartan Picture
Figure Olmesartan Picture
Figure AT1 Receptor Antagonists Sales Market Share by Applications in 2017
Figure Hypertension Picture
Figure Cardiovascular Diseases Picture
Figure Kidney Diseases Picture
Figure Other Picture
Figure United States AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Canada AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Germany AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure France AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure UK AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Russia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Italy AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure China AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Japan AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Korea AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure India AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria AT1 Receptor Antagonists Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer AT1 Receptor Antagonists Type and Applications
Table Pfizer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis AT1 Receptor Antagonists Type and Applications
Table Novartis AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck AT1 Receptor Antagonists Type and Applications
Table Merck AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca AT1 Receptor Antagonists Type and Applications
Table Astra Zeneca AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table Jhonson and Johnson AT1 Receptor Antagonists Type and Applications
Table Jhonson and Johnson AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company AT1 Receptor Antagonists Type and Applications
Table Eli Lilly and Company AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi SA Basic Information, Manufacturing Base and Competitors
Table Sanofi SA AT1 Receptor Antagonists Type and Applications
Table Sanofi SA AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb AT1 Receptor Antagonists Type and Applications
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer AT1 Receptor Antagonists Type and Applications
Table Bayer AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK AT1 Receptor Antagonists Type and Applications
Table GSK AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical AT1 Receptor Antagonists Type and Applications
Table Teva Pharmaceutical AT1 Receptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global AT1 Receptor Antagonists Sales by Manufacturer (2016-2017)
Figure Global AT1 Receptor Antagonists Sales Market Share by Manufacturer in 2016
Figure Global AT1 Receptor Antagonists Sales Market Share by Manufacturer in 2017
Table Global AT1 Receptor Antagonists Revenue by Manufacturer (2016-2017)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Manufacturer in 2016
Figure Global AT1 Receptor Antagonists Revenue Market Share by Manufacturer in 2017
Figure Top 3 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Top 6 AT1 Receptor Antagonists Manufacturer (Revenue) Market Share in 2017
Figure Global AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Regions (2013-2018)
Table Global AT1 Receptor Antagonists Sales Market Share by Regions (2013-2018)
Table Global AT1 Receptor Antagonists Revenue by Regions (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2013
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2017
Figure North America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure North America AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table North America AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table North America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure North America AT1 Receptor Antagonists Sales Market Share by Countries in 2013
Figure North America AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table North America AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table North America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure North America AT1 Receptor Antagonists Revenue Market Share by Countries in 2013
Figure North America AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure United States AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Canada AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Mexico AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Europe AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Europe AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Table Europe AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2016
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Germany AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UK AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure France AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Russia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Italy AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Asia-Pacific AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Countries 2017
Table Asia-Pacific AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue Market Share by Countries 2017
Figure China AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Japan AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Korea AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure India AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Southeast Asia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South America AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table South America AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table South America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure South America AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table South America AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table South America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure South America AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Brazil AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Argentina AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Colombia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue and Growth Rate (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Countries (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries in 2017
Table Middle East and Africa AT1 Receptor Antagonists Revenue by Countries (2013-2018)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries in 2013
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries in 2017
Figure Saudi Arabia AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure UAE AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Egypt AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure Nigeria AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Figure South Africa AT1 Receptor Antagonists Sales and Growth Rate (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Type (2013-2018)
Table Global AT1 Receptor Antagonists Sales Share by Type (2013-2018)
Table Global AT1 Receptor Antagonists Revenue by Type (2013-2018)
Table Global AT1 Receptor Antagonists Revenue Share by Type (2013-2018)
Figure Global Valsartan Sales Growth (2013-2018)
Figure Global Valsartan Price (2013-2018)
Figure Global Telmisartan Sales Growth (2013-2018)
Figure Global Telmisartan Price (2013-2018)
Figure Global Losartan Sales Growth (2013-2018)
Figure Global Losartan Price (2013-2018)
Figure Global Irbesartan Sales Growth (2013-2018)
Figure Global Irbesartan Price (2013-2018)
Figure Global Azilsartan Sales Growth (2013-2018)
Figure Global Azilsartan Price (2013-2018)
Figure Global Olmesartan Sales Growth (2013-2018)
Figure Global Olmesartan Price (2013-2018)
Table Global AT1 Receptor Antagonists Sales by Application (2013-2018)
Table Global AT1 Receptor Antagonists Sales Share by Application (2013-2018)
Figure Global Cardiovascular Diseases Sales Growth (2013-2018)
Figure Global Kidney Diseases Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global AT1 Receptor Antagonists Sales, Revenue and Growth Rate (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Regions (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Regions (2018-2023)
Figure North America Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Europe Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Asia-Pacific Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure South America Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Figure Middle East and Africa Sales AT1 Receptor Antagonists Market Forecast (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Type (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Type (2018-2023)
Table Global AT1 Receptor Antagonists Sales Forecast by Application (2018-2023)
Table Global AT1 Receptor Antagonists Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
